CHANGE IN RATINGS
upgraded at Goldman Sachs to Buy from Neutral due to better growth opportunities and more reliable earnings than peers. See superior returns driven by larger scale. Price target at $33.
upgraded at Citigroup from Hold to Buy. $40 price target. Expect the steel market to recover, and the stock looks attractive following a 20% sell-off.
upgraded at Citigroup from Hold to Buy. Earnings were lower last quarter because of a higher tax rate, but sales growth trends remain strong. Core products are also taking market share, and earnings upside now seems possible. $60 price target.
Cooper Companies numbers lowered at Jefferies. Price target dips to $46 from $48 and 2008 EPS estimates drop to $2.80 from $2.85. Reiterates Hold rating.
upgraded at JP Morgan to Neutral. Commercial paper market concerns are overblown for high-quality managers like Federated.
upgraded at Bernstein from Underperform to Market Perform. $36 price target. Potential downside appears limited from current levels, despite continued credit concerns.
initiated at Morgan Stanley with an equalweight rating and $58 price target.
downgraded to Neutral from Buy at Suntrust Robinson Humphrey. Earnings could fall below consensus estimates, as the finance and accounting staffing markets should slow down.
Nabors upgraded at Bernstein from Market Perform to Outperform. Valuation call, as the land rig market still has good visibility.
downgraded at Morgan Stanley from overweight to equalweight and moves price target to $30.
upgraded at Deutsche Bank from Hold to Buy. $72 price target. Estimates raised to reflect low natural gas prices and higher oil.
upgraded at Bernstein from Market Perform to Outperform. Valuation call, as earnings expectations have moderated.
upgraded at Friedman, Billings Ramsey to Outperform. $45 price target. Valuation call, as the company is trading at a steep discount to its net asset value.
upgraded at CIBC from Sector Perform to Outperform. $40 price target. Company hosted a very bullish analyst meeting, saying that customer demand remains very strong.
( WYE) downgraded at Citigroup from Buy to Hold. $51 price target. Company has disappointed lately, and the entire drug sector will likely struggle over the coming quarters.
upgraded at Citigroup from Hold to Buy. $118 price target. Estimates also raised to reflect recent acquisitions and improving industry fundamentals.
STOCK COMMENTS / EPS CHANGES
numbers raised at Jefferies. Price target lifts to $56 from $55 and 2008 EPS estimates upped to $2.60 from $2.55. Reiterates Buy rating.
2007 estimates slashed at Goldman to $2.85 from $4.25 based on new North American sales and production estimate following weak August sales. Price target cut to $37 from $42. Reiterated Buy rating.
numbers lowered at UBS. Price target slashed to $33 from $40 and 2008 EPS estimate drops to $2.95 from $3.40. Reiterates Neutral rating.
2007 estimates cut at Credit Suisse to $1.86 from $1.95 due to declining margins and a tough road ahead. Maintained Outperform rating.
Office Depot 2007 estimates lowered at Goldman to $1.90 from $2.05 based on management commentary at Goldman's retailing conference. Key issues are ongoing macroeconomic pressure, intensified back-to-school promotions, and ongoing investments in delivery business. Maintained Neutral rating and cut price target to $29 from $32.